SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 186 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $20,549,125 | -47.8% | 179,437 | -37.2% | 0.80% | -46.4% |
| Q1 2023 | $39,371,553 | +115.6% | 285,653 | +102.6% | 1.50% | +117.2% |
| Q4 2022 | $18,265,467 | -0.4% | 140,959 | -15.1% | 0.69% | -8.1% |
| Q3 2022 | $18,345,000 | +15.3% | 165,959 | -21.8% | 0.75% | +20.2% |
| Q2 2022 | $15,904,000 | -10.6% | 212,165 | -6.8% | 0.62% | 0.0% |
| Q1 2022 | $17,788,000 | -37.5% | 227,697 | -27.9% | 0.62% | -31.7% |
| Q4 2021 | $28,447,000 | -27.9% | 315,897 | -25.9% | 0.92% | -28.0% |
| Q3 2021 | $39,444,000 | +162.6% | 426,514 | +120.7% | 1.27% | +160.2% |
| Q2 2021 | $15,021,000 | +56.3% | 193,224 | +49.8% | 0.49% | +47.4% |
| Q1 2021 | $9,613,000 | -72.7% | 128,987 | -37.5% | 0.33% | -73.2% |
| Q4 2020 | $35,204,000 | +21.4% | 206,487 | 0.0% | 1.24% | +13.8% |
| Q3 2020 | $28,997,000 | +29.1% | 206,487 | +47.4% | 1.09% | +27.1% |
| Q2 2020 | $22,468,000 | +63.9% | 140,129 | 0.0% | 0.86% | +37.9% |
| Q1 2020 | $13,707,000 | -41.5% | 140,129 | -22.8% | 0.62% | -30.0% |
| Q4 2019 | $23,437,000 | +121.8% | 181,623 | +29.5% | 0.89% | +92.2% |
| Q3 2019 | $10,566,000 | -53.0% | 140,279 | -5.1% | 0.46% | -49.7% |
| Q2 2019 | $22,465,000 | +27.5% | 147,847 | 0.0% | 0.92% | +28.1% |
| Q1 2019 | $17,622,000 | -15.8% | 147,847 | -22.9% | 0.72% | -20.1% |
| Q4 2018 | $20,935,000 | -41.9% | 191,837 | -14.0% | 0.90% | -31.4% |
| Q3 2018 | $36,046,000 | +16.3% | 223,182 | -4.8% | 1.31% | +11.1% |
| Q2 2018 | $30,995,000 | +10.5% | 234,489 | -38.1% | 1.18% | +7.8% |
| Q1 2018 | $28,044,000 | +50.7% | 378,516 | +13.2% | 1.09% | +51.9% |
| Q4 2017 | $18,606,000 | -23.6% | 334,400 | -37.7% | 0.72% | -17.5% |
| Q3 2017 | $24,340,000 | +41.1% | 536,600 | +4.9% | 0.87% | +36.2% |
| Q2 2017 | $17,246,000 | +13.9% | 511,600 | 0.0% | 0.64% | +8.9% |
| Q1 2017 | $15,143,000 | +18.4% | 511,600 | +9.7% | 0.59% | +7.7% |
| Q4 2016 | $12,791,000 | -2.7% | 466,300 | +117.8% | 0.54% | +7.7% |
| Q3 2016 | $13,148,000 | +186.6% | 214,100 | -38.0% | 0.51% | +178.0% |
| Q1 2015 | $4,587,000 | -8.2% | 345,400 | 0.0% | 0.18% | -22.2% |
| Q4 2014 | $4,998,000 | -65.7% | 345,400 | -50.0% | 0.23% | -65.8% |
| Q3 2014 | $14,576,000 | – | 690,800 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |